A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
An international coalition of experts in laboratory medicine, osteoporosis, and chronic kidney disease is calling for laboratories to stop the routine reporting of albumin-adjusted (“corrected”) calcium. The group argues the longstanding practice is outdated, unreliable in many clinical settings, and potentially harmful to patients.
The recommendation is detailed in a new position statement published in the journal Clinical Chemistry and Laboratory Medicine. The statement was developed by a working group representing the European Federation of Clinical Chemistry and Laboratory Medicine Committee: Chronic Kidney Diseases, the Joint International Osteoporosis Foundation (IOF) Working Group, and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Bone Metabolism.
For decades, laboratories have used mathematical formulas to adjust total calcium levels based on albumin concentration. This practice assumes the adjustment provides a more accurate estimate of biologically active calcium. However, the authors state that evidence shows these formulas perform poorly, particularly in patients with chronic illness, kidney disease, inflammation, acid-base disturbances, or low albumin levels.
“Albumin-adjusted calcium has become deeply embedded in clinical practice despite limited validation against ionised calcium, which is the biologically active form,” says Etienne Cavalier, lead author, University of Liege, and chair of the Joint IOF Working Group and IFCC Committee on Bone Metabolism, in a release. “Current evidence indicates that these corrections can actually worsen diagnostic accuracy and mask clinically important abnormalities.”
Diagnostic Accuracy and Patient Impact
The statement highlights recent large-scale studies indicating that unadjusted total calcium often aligns better with ionized calcium than common correction formulas. In certain instances, corrected calcium may falsely normalize true hypocalcemia or incorrectly suggest hypercalcemia.
These discrepancies are especially critical for patients with advanced chronic kidney disease or those receiving dialysis. In these populations, calcium balance directly influences treatment decisions involving vitamin D analogues, calcimimetics, phosphate binders, and dialysis prescriptions.
The authors also note that albumin correction introduces additional analytical uncertainty and lacks standardization across laboratories. Results vary depending on local albumin measurement methods and specific patient populations.
Recommendations for Laboratories
Instead of routine correction, the expert groups recommend that laboratories:
Reporting total calcium as the default laboratory result
Ordering ionized calcium when calcium status is clinically important or difficult to interpret
Using ionized calcium as the preferred first-line test in patients with severe hypoalbuminemia or those on dialysis, provided appropriate quality and sampling standards are followed
The paper also identifies significant international variability in current laboratory practice. Some laboratories never report corrected calcium, while others generate it automatically whenever calcium and albumin are measured together.
The authors conclude that abandoning routine albumin-adjusted calcium reporting would improve consistency, reduce diagnostic confusion, and better align laboratory medicine with contemporary evidence and physiology.
ID 133073120 | Calcium Periodic Table © Violka08 | Dreamstime.com
